PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
IQ4I Research & Consultancy Pvt. Ltd.

Press Release


Receive press releases from IQ4I Research & Consultancy Pvt. Ltd.: By Email RSS Feeds:

IQ4I Research & Consultancy Published a New Report on "Non-Alcoholic Steatohepatitis (NASH) Pipeline Analysis"


The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins and RNA-based therapeutics, but excludes Off-label, symptom relief drugs, generic combinations.

Boston, MA, July 18, 2015 --(PR.com)-- “Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins and RNA-based therapeutics, but excludes Off-label, symptom relief drugs, generic combinations. The report also covers hot targets in research for NASH treatments and disease progression biomarkers.

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Nonalcoholic steatohepatitis (NASH) Drug market. The report also provides strategic insights on medicines that are likely to have an impact on future NASH treatment space.

Some of the key sections covered in the report are given below:

Epidemiology
In this section, epidemiology of NASH is reviewed to understand potential significance and impact of the disease.
Global & US prevalence rates
Contact Information
IQ4I Research & Consultancy Pvt. Ltd.
Satish Birudukota
+91 8060500229
Contact
iq4i.com

Click here to view the list of recent Press Releases from IQ4I Research & Consultancy Pvt. Ltd.
Promote Your Business